Get the Stockscreener App
2.38
10.19%
-0.27
After Hours:
2.39
0.01
+0.42%
Inovio Pharmaceuticals Inc stock is traded at $2.38, with a volume of 2.46M.
It is down -10.19% in the last 24 hours and up +59.73% over the past month.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
See More
Previous Close:
$2.65
Open:
$2.66
24h Volume:
2.46M
Relative Volume:
1.12
Market Cap:
$126.48M
Revenue:
$832.00K
Net Income/Loss:
$-135.12M
P/E Ratio:
-0.3908
EPS:
-6.09
Net Cash Flow:
$-124.69M
1W Performance:
-14.70%
1M Performance:
+59.73%
6M Performance:
+16.10%
1Y Performance:
-64.10%
1-Day Range:
$2.38
$2.6689
1-Week Range:
$2.38
$2.9789
52-Week Range:
$1.30
$7.00
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Name
Inovio Pharmaceuticals Inc
Sector
Industry
Phone
(858) 410-3134
Address
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Compare INO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.38 | 140.30M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-14-24 | Initiated | Stephens | Overweight |
| Jan-25-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-09-22 | Downgrade | Maxim Group | Buy → Hold |
| Nov-01-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-19-22 | Resumed | RBC Capital Mkts | Sector Perform |
| May-11-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-21-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-29-21 | Resumed | Jefferies | Hold |
| Sep-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-24-21 | Initiated | Jefferies | Hold |
| Mar-23-21 | Initiated | BofA Securities | Neutral |
| Feb-12-21 | Initiated | Oppenheimer | Outperform |
| Nov-17-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Nov-10-20 | Upgrade | ROTH Capital | Sell → Neutral |
| Sep-28-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-28-20 | Upgrade | Maxim Group | Hold → Buy |
| Jul-01-20 | Downgrade | Maxim Group | Buy → Hold |
| Jul-01-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Jun-29-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-26-20 | Downgrade | Stifel | Buy → Hold |
| May-21-20 | Initiated | The Benchmark Company | Buy |
| Apr-30-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Mar-13-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-13-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-19-19 | Initiated | ROTH Capital | Buy |
| Feb-15-18 | Reiterated | Maxim Group | Buy |
| Oct-18-17 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-17 | Initiated | Citigroup | Buy |
| Jun-08-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-24-17 | Reiterated | Maxim Group | Buy |
| Mar-16-17 | Upgrade | Maxim Group | Hold → Buy |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
View All
Inovio Pharmaceuticals Inc Stock (INO) Latest News
Nuveen LLC Acquires Shares of 103,297 Inovio Pharmaceuticals, Inc. $INO - MarketBeat
Inovio Pharmaceuticals (NASDAQ:INO) Downgraded to "Hold" Rating by Zacks Research - MarketBeat
Recurrent Respiratory Papillomatosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Precigen, Inovio Pharma - Barchart.com
Inovio Pharmaceuticals Inc. At Decision Level — Rebound or Resistance2025 Breakouts & Breakdowns & Daily Momentum Trading Reports - beatles.ru
Published on: 2025-09-06 13:36:33 - Newser
What is Inovio Pharmaceuticals Inc.’s market position2025 Technical Overview & Weekly Consistent Profit Watchlists - خودرو بانک
Ranking Inovio Pharmaceuticals Inc. among high performing stocks via tools - Newser
Does Inovio Pharmaceuticals Inc. have pricing powerQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - خودرو بانک
Does Inovio Pharmaceuticals Inc. meet Warren Buffett’s criteriaPrice Action & Daily Volume Surge Signals - خودرو بانک
Can Inovio Pharmaceuticals Inc. maintain sales growthEarnings Overview Summary & Weekly High Potential Alerts - خودرو بانک
Visual trend scoring systems applied to Inovio Pharmaceuticals Inc.Market Risk Summary & Verified Swing Trading Watchlist - Newser
Inovio Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Rallies & High Yield Stock Recommendations - Newser
Will a bounce in Inovio Pharmaceuticals Inc. offer an exit2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Inovio at H.C. Wainwright: Progress on DNA Medicine By Investing.com - Investing.com Canada
Inovio Pharmaceuticals shares fall 1.82% intraday after presenting at H.C. Wainwright conference. - AInvest
Is Inovio Pharmaceuticals Inc. benefiting from innovation trendsJuly 2025 Chart Watch & Fast Gaining Stock Reports - خودرو بانک
Inovio at H.C. Wainwright: Progress on DNA Medicine - Investing.com
Historical volatility pattern of Inovio Pharmaceuticals Inc. visualized2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
Custom watchlist performance reports with Inovio Pharmaceuticals Inc.July 2025 Macro Moves & Weekly High Return Stock Forecasts - Newser
Will Inovio Pharmaceuticals Inc. stock recover after recent drop2025 Historical Comparison & Advanced Swing Trade Entry Plans - Newser
How to build a dashboard for Inovio Pharmaceuticals Inc. stockGap Up & Free Expert Approved Momentum Trade Ideas - Newser
Pattern recognition hints at Inovio Pharmaceuticals Inc. upsidePortfolio Update Report & Verified Momentum Stock Alerts - Newser
How institutional ownership impacts Inovio Pharmaceuticals Inc. stockLong Setup & Technical Pattern Alert System - Newser
Combining price and volume data for Inovio Pharmaceuticals Inc.Portfolio Gains Report & Long Hold Capital Preservation Plans - Newser
Exit strategy if you’re trapped in Inovio Pharmaceuticals Inc.2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser
Is Inovio Pharmaceuticals Inc. a candidate for recovery playMarket Sentiment Report & Growth Focused Stock Reports - Newser
Inovio Pharmaceuticals Inc. stock prediction for this week2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - Newser
Detecting support and resistance levels for Inovio Pharmaceuticals Inc.July 2025 Decliners & Weekly Market Pulse Updates - Newser
What MACD and RSI say about Inovio Pharmaceuticals Inc.July 2025 Catalysts & Risk Controlled Stock Pick Alerts - Newser
Using data filters to optimize entry into Inovio Pharmaceuticals Inc.2025 Analyst Calls & Capital Protection Trading Alerts - Newser
What’s the recovery path for long term holders of Inovio Pharmaceuticals Inc.Weekly Volume Report & Verified Stock Trade Ideas - Newser
Is Inovio Pharmaceuticals Inc. stock poised for growthMarket Trend Review & Smart Allocation Stock Reports - Newser
How to forecast Inovio Pharmaceuticals Inc. trends using time seriesEarnings Overview Summary & AI Powered Market Trend Analysis - Newser
Inovio Pharmaceuticals Inc. Could See a Relief Rally From SupportEarnings Overview Summary & Fast Gaining Stock Strategy Reports - beatles.ru
Inovio Pharmaceuticals Inc. stock daily chart insightsPrice Action & Stock Market Timing Techniques - Newser
Gainers Report: Can Inovio Pharmaceuticals Inc. be recession proofJuly 2025 Fed Impact & Reliable Volume Spike Trade Alerts - خودرو بانک
Sector ETF performance correlation with Inovio Pharmaceuticals Inc.Portfolio Gains Report & Daily Technical Forecast Reports - Newser
Reversal indicators forming on Inovio Pharmaceuticals Inc. stock2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Can Inovio Pharmaceuticals Inc. outperform in the next rallyJuly 2025 Big Picture & Free Safe Entry Trade Signal Reports - خودرو بانک
Comparing Inovio Pharmaceuticals Inc. in custom built stock radarsJuly 2025 News Drivers & Proven Capital Preservation Tips - Newser
Advanced analytics toolkit walkthrough for Inovio Pharmaceuticals Inc.July 2025 Macro Moves & Verified Entry Point Signals - Newser
Published on: 2025-09-02 16:02:26 - Newser
Will Inovio Pharmaceuticals Inc. stock recover after earningsJuly 2025 Recap & Verified Momentum Stock Watchlist - خودرو بانک
Inovio Pharmaceuticals Inc Stock (INO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):